Monoclonal Antibodies for Treatment of COVID-19
Who is eligible for monoclonal antibody treatment?
Any patient 12 years of age or older who has tested positive for COVID-19. Patients experiencing mild/moderate symptoms - without increased oxygen requirements from symptom onset. Patients who a medical provider deems "high-risk" for their symptoms progressing to a severe level.
Patients must be within seven days of when their symptoms started.
Frequently Asked Questions
How does it work?
How is the treatment administered?
TGH Global Emerging Diseases Institute
GEDIclinic@tgh.org | (813) 844-4715
Visit TGH.org/GEDIReferral and complete the GEDI Infusion Center referral form.